SCHEMBL5084829

SCHEMBL5084829

CN(C)CC1CC(n2ccc3c(N)nc(-c4ccc5ccc(-c6ccccc6)nc5c4F)nc32)C1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.40
INSR P06213 3/20 0.40
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL399679 0.78 EGFR (0.49) IGF1RINSR
SCHEMBL5318007 0.76 IGF1R (0.39) IGF1RINSRCYP3A4
SCHEMBL5085319 0.76 IGF1R (0.39) IGF1RINSRCYP3A4
SCHEMBL400019 0.74 IGF1R (0.45) IGF1RINSRCYP3A4
SCHEMBL5139584 0.72 IGF1R (0.40) IGF1RINSRCYP3A4
SCHEMBL400570 0.69 ABL1 (0.42) IGF1RINSR
SCHEMBL401016 0.66 IGF1R (0.40) IGF1RINSR
SCHEMBL399340 0.65 LCK (0.49) IGF1RINSRCYP3A4
SCHEMBL399611 0.65 EGFR (0.43) IGF1RINSR
SCHEMBL399750 0.65 IGF1R (0.61) IGF1RINSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979002-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI Pharmaceuticals, Inc. (US) 2008-10-15 EP disclosed
WO-2007075554-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2007-07-05 WO disclosed